MUNALIFE.me Clinical Pathway Navigator

Iron deficiency carries a cost beyond the blood test. Patients can lose energy, physical capacity and working days, while health systems face greater demand for care. MUNALIFE.me is developing decision support that connects symptoms and iron results with the investigation or specialist referral a patient needs.

The Burden Reaches Healthcare Budgets and Everyday Life

€7,125

Iron Deficiency Group

Average annual healthcare costs for people with diagnosed iron deficiency or iron-deficiency anaemia, including hospital care, outpatient services and prescriptions

€2,685

Comparison Group

Average annual healthcare costs for an age- and sex-matched comparison group

1,749

Working Days Lost

Days of absence recorded among 67 patients with anaemia in a 2015 study of Matosinhos, Portugal

These figures together illustrate why iron deficiency is not merely a laboratory finding. The financial and social consequences extend across health systems, employers and patients themselves. The German study reported that the iron-deficiency group also had more coexisting illnesses, so the cost difference cannot be treated as a direct estimate of avoidable spending. The Portuguese data, drawn from a single health unit, illustrates the scale of working-life disruption that anaemia can produce at a local level. [1, 2]

Care Needs a Clearer Connection Between Findings and the Next Step

87.8%

No Ferritin or Serum Iron Test

In the Portuguese Matosinhos study, this share of patients with laboratory-confirmed anaemia had no recorded serum iron or ferritin measurement during the study period — a gap between a confirmed finding and the investigation needed to explain it. This is precisely the problem MUNALIFE.me is designed to address. [2]

Why the Connection Is Difficult

Multiple Causes

Fatigue, breathlessness and digestive symptoms can each have several causes, making the source difficult to pinpoint from symptoms alone.

Iron Deficiency Without Anaemia

Iron deficiency can be present and clinically significant even when haemoglobin remains within a normal range.

Inflammation Masking Ferritin

Inflammation can raise ferritin levels, complicating its interpretation as a marker of iron stores.

Fragmented Consultations

When results are reviewed across different consultations, systems or specialties, the underlying cause may remain unresolved and the next referral delayed. [3, 5]

The clinical challenge is not identifying that iron is low — it is understanding why, and acting on that understanding with appropriate urgency.

Connect Symptoms and Iron Results to a Focused Clinical Decision

MUNALIFE.me has developed the first draft of an impaired-absorption algorithm, using AI to help analyse clinical guidelines and scientific literature. The clinical rules are being refined and validated, with patient-level output based on fixed, reviewable logic — not opaque model inference.

1

Unified Clinician Workspace

The prototype brings symptoms, medical history and laboratory results into one view. It shows which information is missing, which underlying conditions need investigation and which tests or specialist pathways to consider.

2

Explained Proposed Investigations

Each proposed investigation explains the clinical question, why it matters for this patient and how the result could change the next decision — keeping reasoning transparent and auditable.

3

Dedicated Review Area

Clinical concerns, possible consequences and conditions not to miss remain visible alongside uncertainty. The clinician can inspect the evidence, then accept, defer or reject the proposed action.

4

Wider Pathway Architecture

The full pathway covers insufficient intake, impaired absorption, increased losses and increased physiological demand. The initial backend focuses on absorption; the other branches are in active development.

Synthetic Prototype Example

From Eight Weeks of Fatigue to a Focused Investigation Plan

What the Prototype Identifies

The demonstration highlights possible impaired absorption and proposes coeliac serology — including IgA tTG antibodies and total IgA — alongside completion of the iron assessment. It explains when the findings could support gastroenterology review, without presenting coeliac disease as a confirmed diagnosis. [3, 4]

How the Clinician Engages

The clinician checks the information and decides which actions to take, while other possible causes of the symptoms remain open for assessment. The workflow keeps uncertainty visible and the clinician in control of every proposed step.

What This Example Does Not Claim

The example illustrates the workflow and does not establish clinical performance. It is a synthetic case designed to show how the prototype structures a decision, not a demonstration of validated diagnostic accuracy.

Give the Patient a Plan They Can Understand and Follow

The patient-facing prototype shows submitted information, whether clinician review is pending and the care plan prepared by the clinical team. The plan explains why an investigation has been requested and what happens when the results are available, keeping the patient informed as the case moves between services.

Patients navigating iron deficiency often encounter fragmented communication — a referral arrives without context, a test result is not explained, or the next step is unclear. The patient-facing layer is designed to replace that uncertainty with a structured, readable account of what is happening and why.

For the Hospital

Reduce time spent reconstructing incomplete cases and clarifying referrals between services.

For the Clinician

Make the next decision easier to review, with reasoning and missing information surfaced in one place.

For the Patient

Replace an unclear next step with an understandable plan that follows the case across services.

Why Iron Status Matters Beyond Fatigue

Iron deficiency does not stop at tiredness. Its consequences reach the heart, the lungs and the gut.

Iron supports oxygen transport and energy production in the heart and other muscles. Ferritin helps assess iron stores, while symptoms, inflammation and other results determine what that finding means for care. The clinical significance of iron deficiency extends well beyond tiredness into cardiac, respiratory and gastrointestinal disease. [3, 5]

Heart Failure and Physical Function

Clinical trials in selected patients with heart failure and iron deficiency show that appropriate iron treatment can reduce heart-failure hospitalisations. This makes iron-status assessment a relevant part of the wider cardiac care pathway. [6]

Breathing Symptoms and Respiratory Disease

Breathlessness needs a broader assessment that may include iron status. Research in respiratory disease is less established, so the pathway must keep alternative causes visible and avoid treating iron deficiency as a universal explanation. [5, 7]

Underlying Disease and Earlier Investigation

Unexplained iron-deficiency anaemia can signal blood loss or gastrointestinal disease, including malignancy in some patients. The clinical opportunity is to investigate an important finding and its cause, with urgency and specialist referral determined by the full assessment. [3]

Help Test a Clearer Route from Symptoms to Specialist Care

MUNALIFE.me is seeking a hospital partner to evaluate whether the prototype can help clinicians reach an appropriate next step with less review time and fewer missed indications, without increasing unnecessary tests or referrals.

Proposed First Evaluation

The evaluation compares prototype outputs with independent clinician review using synthetic or appropriately governed retrospective cases. It will test the prevention goal of acting earlier on clinically important findings and identify what needs to change before prospective use.

Discuss a Hospital Pilot

To begin a conversation about a pilot partnership, please share your name, work email and hospital or organisation, along with the clinical pathway you would like to explore. Please do not include patient-identifiable information in any initial enquiry.

Evidence and References

The following published sources underpin the clinical and economic claims made throughout this site. All figures are cited as reported in the original studies and should be interpreted in the context described in each source.